MyriaMeat, a cultivated meat startup based in Munich, has successfully established a pluripotent stem cell line from roe deer and produced functional roe deer muscle cells using its patented differentiation protocol. This marks the first time the company has applied its iPSC platform to a wild game species, expanding beyond its previous focus on pork. The achievement demonstrates the potential for MyriaMeat's technology to be transferred to additional animal species, showcasing its versatility and potential for producing high-value products.

Roe deer is a popular game meat in Germany and Central Europe, making it a strategic choice for MyriaMeat to target due to its consumer demand and premium positioning in culinary markets. By successfully producing roe deer muscle cells, the company showcases the adaptability of its platform and the potential for developing specialty and high-value cultivated meat products. Additionally, the technical achievement of being able to apply the same iPSC differentiation protocol across multiple species could significantly reduce the development cost and timeline for future species targets, positioning MyriaMeat for continued success in the cultivated meat industry.